Furthermore, the chronic administration of a Fractaline analog in various rodent models of obesity improved glucose tolerance, increased β-cell glucose-stimulated insulin secretion, and reduced β-cell apoptosis, highlighting its positive effect in regulating glucose homeostasis [167,168]. The gene discussed is INS; the disease is obesity disorder.